The effect of GR32191 (a thromboxane receptor antagonist) on airway responsiveness in asthma
- 1 September 1992
- journal article
- clinical trial
- Published by Elsevier in Pulmonary Pharmacology
- Vol. 5 (3) , 199-202
- https://doi.org/10.1016/0952-0600(92)90041-e
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Effect of GR32191, a potent thromboxane receptor antagonist, on exercise induced bronchoconstriction in asthma.Thorax, 1991
- Bronchoalveolar lavage fluid mediator levels 5 minutes after allergen challenge in atopic subjects with asthma: Relationship to the development of late asthmatic responsesJournal of Allergy and Clinical Immunology, 1991
- Effect of a thromboxane A2 receptor antagonist (AA-2414) on bronchial hyperresponsiveness to methacholine in subjects with asthmaJournal of Allergy and Clinical Immunology, 1991
- The actions of GR32191B, a thromboxane receptor antagonist, on the effects of inhaled PAF on human airwaysClinical and Experimental Allergy, 1990
- GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitroBritish Journal of Pharmacology, 1989
- The relationship between bronchial responsiveness to methacholine and bronchial responsiveness to histamine in asthmatic subjectsPulmonary Pharmacology, 1988
- Effects of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects.Thorax, 1986
- Effect of beclomethasone dipropionate on bronchial responsiveness to histamine in controlled nonsteroid-dependent asthmaJournal of Allergy and Clinical Immunology, 1985
- Monitoring of maximum expiratory peak flow rates and histamine inhalation tests in the investigation of occupational asthmaClinical and Experimental Allergy, 1984
- Bronchial reactivity to inhaled histamine: a method and clinical surveyClinical and Experimental Allergy, 1977